ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
68,014.71
0.42%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. DICE Therapeutics Inc (DICE)

  7. DICE Therapeutics Inc (DICE) News

DICE Therapeutics (DICE)

DICE Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DICE
DateTimeSourceHeadlineSymbolCompany
21/08/202313:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:DICEDICE Therapeutics Inc
11/08/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DICEDICE Therapeutics Inc
09/08/202321:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DICEDICE Therapeutics Inc
09/08/202321:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DICEDICE Therapeutics Inc
09/08/202321:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DICEDICE Therapeutics Inc
09/08/202321:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DICEDICE Therapeutics Inc
09/08/202321:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DICEDICE Therapeutics Inc
09/08/202321:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DICEDICE Therapeutics Inc
09/08/202314:47Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DICEDICE Therapeutics Inc
09/08/202314:45Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DICEDICE Therapeutics Inc
09/08/202314:42Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DICEDICE Therapeutics Inc
09/08/202314:38Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:DICEDICE Therapeutics Inc
09/08/202314:32Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:DICEDICE Therapeutics Inc
09/08/202314:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DICEDICE Therapeutics Inc
09/08/202314:20Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:DICEDICE Therapeutics Inc
09/08/202314:02PR Newswire (US)Lilly Completes Acquisition of DICE TherapeuticsNASDAQ:DICEDICE Therapeutics Inc
08/08/202321:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DICEDICE Therapeutics Inc
25/07/202312:11Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:DICEDICE Therapeutics Inc
25/07/202311:55PR Newswire (US)Lilly Announces Extension of Tender Offer to Acquire DICENASDAQ:DICEDICE Therapeutics Inc
17/07/202322:23Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:DICEDICE Therapeutics Inc
30/06/202321:22Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:DICEDICE Therapeutics Inc
23/06/202322:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DICEDICE Therapeutics Inc
23/06/202322:11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DICEDICE Therapeutics Inc
22/06/202321:33Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DICEDICE Therapeutics Inc
21/06/202322:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DICEDICE Therapeutics Inc
20/06/202321:07Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:DICEDICE Therapeutics Inc
20/06/202315:15Dow Jones NewsTrending: Eli Lilly Buys DICE Therapeutics in Deal Worth $2.4 BillionNASDAQ:DICEDICE Therapeutics Inc
20/06/202313:21Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:DICEDICE Therapeutics Inc
20/06/202312:42Dow Jones NewsEli Lilly to Acquire DICE Therapeutics for $2.4 BillionNASDAQ:DICEDICE Therapeutics Inc
20/06/202312:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DICEDICE Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DICE

Your Recent History

LSE
ZED
Zenova
LSE
CHLL
Chill Brands
LSE
KEFI
Kefi Gold And Copper
LSE
SAR
Sareum
LSE
GKP
Gulf Keystone Petroleum
LSE
POS
Plexus
LSE
GOLD
LSE
VAST
Vast Resources
LSE
BIRD
Blackbird
LSE
LLOY
Lloyds Banking
LSE
KRS
Keras Resources
LSE
VOD
Vodafone
LSE
GPM
Golden Prospect Precious...
LSE
AVCT
Avacta
LSE
BARC
Barclays
LSE
TERN
Tern
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved